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ABSTRACT
Sleep misperception – the discrepancy between objective and subjective measures of
sleep – has been shown to be prevalent among patients with insomnia and may be a promising
target for sleep intervention. This study examined sleep misperception in a diverse outpatient
medical sample using consumer-grade wearable actigraphs (i.e., Fitbit Charge HR™). Fortyfour self-identified problem sleepers aged 20 to 79 participated in the study. Participants
completed sleep diaries for one week while also tracking their sleep using the Fitbit Charge
HR™. After receiving a personalized sleep report based on these data, participants repeated
another week of sleep assessment. Sleep misperception was observed for both total sleep time
and sleep onset latency during the first week, such that participants underestimated their total
amount of sleep per night and overestimated the amount of time it took them to fall asleep. Prepost changes in self-reported sleep, mood, and health were examined as a secondary aim in this
study. Objectively measured sleep remained relatively unchanged from baseline to follow-up.
Despite this lack of change in actual sleep, participants perceived themselves to be sleeping more
hours per night, falling asleep more quickly, and sleeping better overall at one-week follow-up.
Statistically significant improvements in depression, anxiety, mental health functioning, and
insomnia symptom severity were also observed at follow-up. Overall, findings showed that
sleep misperception is prevalent among problem sleepers and that sleep discrepancy can be
reduced through the use of corrective sleep feedback.

ii

To my mentor, Dr. Cerissa Blaney, who pushed me when I was stuck, believed in me when my
confidence waivered, and supported me when I was not sure that I could make it through. You
are an inspiration as a psychologist, a mother, and a woman. Though words will never fully
convey my gratitude, I dedicate this dissertation to you in thanks and appreciation.

iii

TABLE OF CONTENTS
LIST OF FIGURES ....................................................................................................................... vi
LIST OF TABLES ....................................................................................................................... viii
INTRODUCTION .......................................................................................................................... 1
LITERATURE REVIEW ............................................................................................................... 4
Diagnosis..................................................................................................................................... 4
Development and Course ............................................................................................................ 5
Sleep Measurement ..................................................................................................................... 6
Treatment .................................................................................................................................... 9
Sleep Misperception.................................................................................................................. 12
Sleep Misperception: Patient Characteristics............................................................................ 13
Correcting Sleep Misperceptions .............................................................................................. 15
Summary and Study Aims ........................................................................................................ 17
METHODS ................................................................................................................................... 19
Participants and recruitment ..................................................................................................... 19
Study design and procedures .................................................................................................... 19
Measures ................................................................................................................................... 21
Statistical analyses .................................................................................................................... 25
RESULTS ..................................................................................................................................... 26
Sample characteristics ............................................................................................................... 26
Intervention effects ................................................................................................................... 29
Patient Perceptions of Intervention ........................................................................................... 35
DISCUSSION ............................................................................................................................... 41
iv

APPENDIX A: ISI ........................................................................................................................ 45
APPENDIX B: DBAS-16 ............................................................................................................. 47
APPENDIX C: ESS ...................................................................................................................... 50
APPENDIX D: SF-36 ................................................................................................................... 52
APPENDIX E: PHQ-9 .................................................................................................................. 59
APPENDIX F: GAD-7 ................................................................................................................. 61
APPENDIX G: AUDIT ................................................................................................................ 63
APPENDIX H: CDS-E ................................................................................................................. 65
APPENDIX I: PATIENT SATISFACTION QUESTIONNAIRE ............................................... 70
APPENDIX J: SAMPLE FEEDBACK REPORT ........................................................................ 72
APPENDIX K: IRB APPROVAL LETTER ................................................................................ 75
REFERENCES ............................................................................................................................. 78

v

LIST OF FIGURES
Figure 1. Baseline TST discrepancy ............................................................................................. 28
Figure 2. Baseline SOL discrepancy............................................................................................. 28
Figure 3. Fitbit Mean TST Pre-Post Intervention ......................................................................... 30
Figure 4. Sleep Diary Mean TST Pre-Post Intervention ............................................................... 31
Figure 5. Fitbit Mean SOL Pre-Post Intervention ......................................................................... 31
Figure 6. Sleep Diary Mean SOL Pre-Post Intervention .............................................................. 32
Figure 7. Insomnia Severity Index Pre-Post Intervention ............................................................. 33
Figure 8. Mental Composite Score (SF-36) Pre-Post Intervention ............................................... 34
Figure 9. Physical Composite Score (SF-36) Pre-Post Intervention............................................. 34
Figure 10. Depression scores (PHQ-9) Pre-Post Intervention ...................................................... 35
Figure 11. Anxiety scores (GAD-7) Pre-Post Intervention .......................................................... 35
Figure 12. Perception of feedback as useful ................................................................................. 36
Figure 13. Perception of feedback as informative ........................................................................ 37
Figure 14. Perception of feedback as helpful in understanding sleep ........................................... 37
Figure 15. Perception of Fitbit as accurate ................................................................................... 38
Figure 16. Perception of Fitbit as easy to use ............................................................................... 38
vi

Figure 17. Plan to purchase a Fitbit .............................................................................................. 39
Figure 18. Would recommend study to others .............................................................................. 39
Figure 19. Participants perception of consumer products in routine care..................................... 40

vii

LIST OF TABLES
Table 1. Insomnia diagnostic criteria .............................................................................................. 5
Table 2. Spielman’s 3P Model of Insomnia.................................................................................... 6
Table 3. CBT-I Treatment Components ....................................................................................... 10
Table 4. Participant demographics ................................................................................................ 26
Table 5. Participant characteristics at baseline ............................................................................. 27
Table 6. Sleep discrepancies at baseline and one-week follow-up ............................................... 28
Table 7. Unstandardized regression coefficients for predictors of TST Misperception Index ..... 29
Table 8. Unstandardized regression coefficients for predictors of SOL discrepancy................... 29
Table 9. Differences in sleep features from baseline to follow-up ............................................... 30
Table 10. Differences in self-report measures from baseline to follow-up .................................. 33

viii

INTRODUCTION
Sleep problems are ubiquitous in the modern world and present a significant public health
concern (Matricciani et al., 2017; Pallesen et al., 2014). Self-reported sleep problems are
associated with higher stress levels, lower life satisfaction, and worse health outcomes (NSF,
2014). More than one-third of U.S. adults sleep less than the 7 hour per night minimum
recommended by the National Sleep Foundation (CDC, 2011), consequences of which are welldocumented (Itani et al., 2017). Acute sleep insufficiency has been linked to inflammation
(Irwin, Olmstead, & Carroll, 2016), decreased insulin sensitivity (Czeisler, 2015; van Cauter et
al., 2007), and immunosuppression (Cohen et al., 2009; Prather et al., 2015), whereas, chronic
insufficient sleep has been associated with increased risk for cardiovascular disease (Bhaskar,
Hemavathy, & Prasad, 2016; Taylor et al., 2007), coronary heart disease (Itani et al., 2017),
hypertension (Bathgate et al., 2016), diabetes mellitus (Shan et al., 2015), and obesity (Itani et
al., 2017).
Also associated with short duration sleep are impairments in executive functioning
(Kuula et al., 2017), memory consolidation (Gildner et al., 2014; Prince & Abel, 2013), and
attention (Ahmad & Bashir, 2017; Perez-Lloret et al., 2013). Sleep insufficiency is also
associated with increased risk for mild cognitive impairment (MCI), dementia (Chen et al.,
2016), and cognitive decline in older adults (Lo et al., 2014). Much research has been done on
the impact of sleep disturbance and insufficiency on mood and affective functioning, finding it to
contribute to depression and anxiety as well as more global emotion dysregulation (Coulombe et
al., 2011; Pasch et al., 2010; Watling et al., 2017).
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Taken together, it is clear that sleep impairment has a significant negative impact on
health and wellbeing. It is important to note that this relationship is bi-directional, such that
those with poor health (medical and psychosocial functioning) are also more likely to develop
sleep problems (Mai & Buysse, 2008). Given this reciprocity between sleep and health, it is no
surprise that sleep complaints are prevalent in medical settings. Sleep problems are often first
identified by primary care providers (Edinger & Sampson, 2003; Qaseem et al., 2016; van der
Zweerde et al., 2016). An estimated 20-50% of primary care patients meet full diagnostic
criteria for insomnia (Bjorvatn, Meland, Flo, & Mildestvedt, 2017; Trauer, Qian, Doyle,
Rajaratnam, & Cunningham, 2015; Troxel & Buysse, 2013) and as many as 55% of those
without clinical insomnia report subthreshold sleep problems (Bjorvatn, Meland, Flo, &
Mildestvedt, 2017). Overall, findings suggest that a large majority of adults experience some
degree of sleep difficulty or impairment, with as few as 10% reporting no sleep problems
(Bjorvatn, Meland, Flo, & Mildestvedt, 2017). Further, the rate of sleep problems has increased
significantly over the past two decades and continues to rise, according to epidemiological
studies (Calem et al., 2012; Pallesen et al., 2014).
With mounting evidence for its’ pervasive impact on health, sleep has garnered both
empirical and clinical attention in recent years. In fact, the importance of sleep is so widely
recognized that the National Sleep Foundation (NSF) recommends including it as a vital sign in
routine medical care (Grandner & Malhotra, 2015; Ojile, 2017). To date, researchers have
extensively explored sleep disorders and related problems, including development and
maintenance factors (e.g., biological, psychological, social, behavioral), assessment and
measurement (e.g., polysomnography, actigraphy), current intervention and treatment (e.g.,
pharmacological, cognitive and behavioral), and other potential treatment targets (i.e., sleep
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misperception). The following literature review will describe the research within each of the
listed domains broadly then will explore areas relevant to the present study in greater depth.
Specifically, the concept of sleep misperception will be introduced and discussed in relation to
sleep impairment and health. The present study, which examined sleep misperception as a
clinical symptom and as an intervention target among medical patients, will then be presented
and results discussed.
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LITERATURE REVIEW
Diagnosis
Insomnia is the most common sleep disorder, with prevalence estimates ranging broadly
from 10% to more than 50% worldwide (Bjorvatn et al., 2017; Ohayon & Reynolds, 2009;
Pallesen et al., 2014; Terzano et al., 2004). This observed discrepancy in prevalence rates is
largely believed to be the result of variability in diagnostic criteria across the three major
classification systems used to diagnose insomnia: International Classification of Sleep Disorders
– Third Edition (ICSD-3; AASM, 2014), International Statistical Classification of Diseases and
Related Health Problems – Tenth Revision (ICD-10; World Health Organization, 1992), and
Diagnostic and Statistical Manual of Mental Disorders – Fifth Edition (DSM-5; APA, 2013).
See Table 1.
In order to diagnose insomnia, all three diagnostic manuals require: (1) self-reported
sleep disturbance or difficulty, (2) which causes some form of functional impairment or distress,
(3) despite adequate opportunity and circumstances for sleep. Despite these commonalities, the
minimum frequency and duration of symptoms required for an insomnia diagnosis varies across
each of the classification systems. This is problematic in terms of estimating prevalence rates
and interpreting research in the sleep field, as these findings are based on disparate diagnostic
criteria. Moreover, recent updates to these manuals and their respective classification systems
further compound this diagnostic problem. These diagnostic inconsistencies have sparked debate
amongst sleep researchers, many of whom argue that insomnia may be better understood as
dimensional rather than categorical (Ohayon & Reynolds, 2009). Much of the research included
in this literature review has relied on a clinical diagnosis of insomnia as categorized by one of
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the aforementioned diagnostic manuals; therefore, the term “insomnia” will be used inclusively
for all three classification systems for simplicity.
Table 1. Insomnia diagnostic criteria
ICSD-3 (AASM, 2014)

DSM-5 (APA, 2013)

ICD-10 (WHO, 1992)

Sleep
disturbance/
complaint

Difficulty initiating sleep, maintaining sleep (frequent awakenings or
difficulty returning to sleep after awakenings), waking up earlier than
desired with an inability to return to sleep

Consequence(s)

One or more of the following related to
the nighttime sleep difficulty:
1. Fatigue/malaise
2. Attention, concentration, or memory
impairment
3. Impaired social, family, occupational,
or academic performance
4. Mood disturbance, irritability
5. Daytime sleepiness
6. Behavioral problems (e.g.,
hyperactivity, impulsivity, aggression)
7. Reduced motivation, energy, initiative
8. Proneness for errors, accidents
9. Concerns about or dissatisfaction with
sleep

Frequency

Sleep disturbance occurs at least 3 times per week

No minimum

Duration

≥ 3 months (Chronic)
< 3 months (Short-Term)

At least 1 month

Opportunity

Sleep disturbance must occur in the presence of adequate opportunity and circumstances for
sleep
Sleep difficulties are not better explained by another sleep disorder, psychological disorder, or
medical condition and are not attributed to the physiologic effects of a substance

Differential
diagnosis

Difficulty initiating or
maintaining sleep, or
nonrestorative sleep

Clinically significant
distress or impairment in
social, occupational,
educational, academic,
behavioral, or other
important areas of
functioning

At least 3 months

Development and Course
Spielman’s 3P Model of Insomnia (Table 2) is one of the most widely recognized models
for the development and maintenance of insomnia, offering an integrated explanation and
framework for insomnia and its’ multiple determinants (Spielman, 1986; Williams, Roth,
Vatthauer, & McCrae, 2013). Briefly, this model asserts that individuals who develop insomnia
possess predisposing factor(s) that make them susceptible to the disorder (i.e., biological or
psychological characteristics that increase one’s vulnerability for developing sleep problems).
When exposed to a precipitating event, such as an illness or life stressor, these individuals are at
5

increased risk for developing acute insomnia symptoms. For some, these symptoms will be
time-limited and will remit when the stressor is removed, whereas others will develop
maladaptive responses such as problematic behaviors, thoughts, or beliefs about sleep which will
serve as the perpetuating mechanisms that maintain the sleep disturbance and lead to chronic or
more severe sleep problems.
Table 2. Spielman’s 3P Model of Insomnia
Definition
Biological and psychological factors
Predisposing
that increase risk of developing a sleep
factors
disorder

Examples
Age (>60), anxiety, hyperactive
arousal system

Precipitating
events

Situational, medical, psychosocial, and
environmental triggers for sleep
problems

Deadlines, illness, travel, stressful
life events

Perpetuating
mechanisms

Behaviors and thoughts or beliefs that
alcohol use, naps, extending time
exacerbate or perpetuate sleep problems in bed, worry about ability to
sleep, fear of sleeplessness

Spielman’s model aptly illustrates the negative cascade of events that leads to the
development of more complex and severe sleep problems. Notably, these factors are largely
modifiable. As such, early identification of patients with sleep problems offers a golden
opportunity for prevention and may allow for early intervention to minimize the negative impact
of acute sleep disturbance and prevent the development of chronic sleep problems.
Sleep Measurement
Polysomnography (PSG) is the current gold standard measure in sleep assessment (Kapur
et al., 2017). Broadly, PSG provides a measure of sleep architecture, including sleep continuity,
neural activity, and time spent in each stage of sleep (Kapur et al., 2017; Togeiro & Smith,
2005). It is typically conducted in a sleep laboratory for a period of one night. PSG is used
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primarily to diagnose breathing-related sleep conditions, such as Obstructive Sleep Apnea (OSA;
Kapur et al., 2017; Ong, Arnedt, & Gehrman, 2017). Though PSG is the gold standard, it is
costly and impractical as a tool for assessing insomnia in routine clinical settings. A major
limitation of traditional PSG is that patients are required to complete an overnight sleep study in
a laboratory setting. Not only is this often aversive to patients but sleep patterns are also likely
to be influenced by the lab environment itself and may not be representative of a patient’s typical
sleep patterns at home (Nissen et al., 2015).
One alternative to the traditional lab-based sleep study is ambulatory (or portable) PSG.
A major benefit of ambulatory PSG is that it can be completed independently in the home,
thereby reducing patient burden and the risk of environmental influence on sleep recordings
(Kapur et al., 2017). Patients are provided a portable monitor which records blood oxygenation
levels, airflow, and respiratory effort, at minimum. Sleep is recorded for one or more nights and
data is extracted by a sleep technician or specialist for interpretation. The Portable Monitoring
Task Force of the American Academy of Sleep Medicine recommends that it be used when
moderate to severe OSA is suspected and no other sleep disorders are present or suspected
(Collop et al., 2007). Though ambulatory PSG addresses some of the limitations of traditional
PSG, it is not a viable option for insomnia assessment in routine clinical practice.
Actigraphy is a more economical and accessible option that can be more readily
integrated into clinical practice to objectively evaluate sleep problems. Actigraphy uses
accelerometer technology to measure bodily movement. Specifically, triaxial accelerometry
measures movement on three planes which is interpreted as a proxy for sleep disturbance.
Actigraphs may be worn on the wrist or ankle and are typically the approximate size of a
wristwatch. Research- and medical-grade actigraphy has been found to have good agreement
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(90%) with PSG and high sensitivity (90- 95%; Sadeh, 2011; Rupp & Balkin, 2011) for detecting
a sleep state, though specificity is lower (50-65%) for detecting awakenings (Rupp & Balkin,
2011). Though it is not a replacement for PSG, actigraphy can be used to characterize sleep and
circadian patterns and to evaluate response to treatment (Buysse et al., 2010; Kay et al., 2015).
In fact, actigraphy (research/medical grade) is now listed in the Federal Register as an approved
method of assessment for patients with insomnia symptoms (minimum of 72 hours to 14
consecutive days of recording). It is recommended that patients complete a sleep log in
conjunction with actigraphy to provide a more comprehensive clinical picture (sleep diary entry
examples: lights off, lights on, out of bed, actigraph off for shower, estimated TST, sleep
latency) (Federal Register).
Commercially available actigraphs have also increased in popularity over the past several
years and produce enormous amounts of patient-generated health data (PGHD). Despite their
widespread use, these devices and their resultant PGHD are not widely used in clinical practice.
Though many healthcare providers are eager to incorporate this data into assessment and
treatment planning, no guidelines currently exist. Research is burgeoning in this area but is
largely still in its’ infancy. Recent research has examined the concordance of sleep data derived
from various consumer activity monitors compared to research- and medical-grade actigraphs
and PSG (de Zambotti, Baker, & Colrain, 2015; de Zambotti et al., 2016; Mantua, Gravel, &
Spencer, 2016).
One validation study compared a commercially available actigraph (Jawbone UP™) to
PSG in a sample of 65 healthy individuals between the ages of 12 and 22 (de Zambotti, Baker, &
Colrain, 2015). This study found good agreement between measures for total sleep time (85%
within range) and wake after sleep onset (89% within range), based on a priori determined limits,
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but found the Jawbone UP™ to overestimate sleep efficiency and underestimate wake after sleep
onset (de Zambotti, Baker, & Colrain). Similar results were found for four other commercially
available actigraphs (Basis Health Tracker, Misfit Shine, Fitbit Flex, Withings Pulse O2) when
compared to the Actiwatch Spectrum research-grade actigraph and PSG among a sample of 40
healthy young adults (Mantua, Gravel, & Spencer, 2016). This study found strong correlations
between PSG and all actigraph devices for TST (r=0.84-0.97, p<0.05), with the Fitbit Flex
(r=0.97) being most strongly correlated with PSG (Mantua, Gravel, & Spencer, 2016). In a
validation study of the Fitbit Charge HR™ researchers employed a third-party research platform
(Fitabase™) for data collection, which allowed them to examine sleep data in 60-second epochs,
similar to research-grade actigraph output (de Zambotti et al., 2016). The Fitbit Charge HR™
was found to have high overall agreement with PSG (91% within range) and high sensitivity
(97%) for detecting sleep. Similar to validation studies with research-grade actigraphs,
specificity for detecting wake (42%) was found to be low for the Fitbit Charge HR™ (de
Zambotti et al., 2016).
Findings to date indicate that many commercially available actigraphs have good
agreement with PSG for TST and have similar sensitivity and specificity to research- and
medical-grade actigraph devices (Baron et al., 2018). Taken together, these findings suggest that
commercial actigraphs may be a promising tool in sleep assessment and warrant further
exploration, both for evaluative and intervention purposes.
Treatment
Cognitive Behavioral Therapy for Insomnia (CBT-I) is the current gold-standard
treatment recommended by the American Academy of Sleep Medicine (AASM) for patients with
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insomnia and related sleep problems (Morgenthaler, Kramer, Alessi, Boehlecke, & Brown, 2006;
Qaseem et al., 2016). CBT-I is a multicomponent treatment that addresses the perpetuating
mechanisms implicated in the development and maintenance of insomnia (Williams et al., 2013).
Specifically, CBT-I targets the behaviors, cognitions, and beliefs that negatively impact sleep
(Perlis, Jungquist, Smith, & Posner, 2006; Riemann & Perlis, 2009). CBT-I treatment
components are detailed in Table 3.
Table 3. CBT-I Treatment Components
Description
Stimulus Control
Sleep Hygiene

Sleep Restriction

Behavioral intervention to strengthen association between bed and sleep and
undermine conditioned response of wakefulness in bed
Guidelines for developing healthy habits to promote sleep, such as eliminating
caffeine later in the day, reducing alcohol consumption, developing a relaxing
bedtime routine, and creating a positive sleep environment
Behavioral intervention aimed at increasing sleep drive and improving sleep
efficiency (SE) by reducing time in bed to match the patient’s current perceived
TST and adjusting over time to achieve >85% SE

Relaxation
Training

Techniques to promote relaxation, reduce cognitive arousal, and ease muscle
tension to facilitate sleep

Cognitive
Restructuring

Cognitive intervention aimed at identifying, challenging, and replacing
dysfunctional beliefs and attitudes about sleep, such as unrealistic sleep
expectations, overestimated consequences of disturbed sleep, and fear of sleep
loss

Despite substantial evidence (see meta-analysis by Trauer et al., 2015) and guidelines
recommending CBT-I (e.g., AASM, American College of Physicians, Agency for Healthcare
Research and Quality), it is rarely implemented outside of specialty sleep medicine practices
(Edinger & Sampson, 2003; Espie MacMahon, Kelly, Broomfield, Douglas, Engleman et al.,
2007). Often, CBT-I is unavailable due to geographic restrictions limiting access to trained
providers. Many patients are also ambivalent about seeking specialty sleep medicine services
which may be burdensome to them due to the time commitment (CBT-I requires ~4-8 sessions),
insurance co-payments, out of pocket fees, and lost wages. Despite empirical support and
10

endorsement for the widespread use of CBT-I, limitations in healthcare workforce training
restrict access to treatment and for those who do have access to behavioral sleep medicine
specialists trained in CBT-I, treatment duration and cost can be barriers.
Given these limitations, it is not surprising that pharmacological intervention is the most
common first-line treatment used in clinical practice. Prescription sleep aids are widely used in
primary care (van der Zweerde et al., 2016; Edinger & Sampson, 2003), with benzodiazepines
(e.g., flurazepam, temazepam) and non-benzodiazepine receptor agonists (e.g., zolpidem,
eszopiclone, zaleplon) being prescribed most frequently (Hoebert, Souverein, Mantel-Teeuwisse,
Leufkens, & van Dijk, 2012). Approximately 60% of primary care patients with insomnia
symptoms are prescribed benzodiazepine-related medication (van der Zweerde et al., 2016).
Consequences of these medications are notable, including unwanted side effects (e.g.,
headaches, dizziness, daytime fatigue), rebound insomnia, and high potential for abuse and
dependence (Qaseem, Kansagara, Forciea, Cooke, & Denberg, 2016; Pigeon, Bishop, & Marcus,
2014). Though pharmacological treatment can be effective for short-term sleep management, it
is not supported for long-term treatment (Qaseem et al., 2016). Similarly, over-the-counter
(OTC) sleep aids (e.g., diphenhydramine) provide short-term relief due to their sedating effects
(Pigeon, Bishop, & Marcus, 2014). However, patients tend to habituate rapidly and may develop
a tolerance within as few as 4 days (Pigeon, Bishop, & Marcus, 2014); therefore, OTC sleep aids
are not indicated for long-term management of sleep problems either. Moreover, prescription
and OTC sleep aids are often contraindicated for patients with multiple morbidities, cardiac or
respiratory illness, cognitive impairment, and for older adults (Williams et al., 2013). Given the
current limitations of both medication sleep aids and non-pharmacological treatments,
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researchers have continued to explore alternative modalities and mechanisms to target in sleep
treatment.
Sleep Misperception
Sleep misperception, also known as sleep discrepancy, has been identified as a potential
treatment target. Sleep misperception – discrepancy between subjective reports and objective
measures (e.g., polysomnography, actigraphy) of sleep disturbance – is a widely observed
phenomenon among problem sleepers and insomniacs (Moon, Song, & Cho, 2015; Harvey &
Tang, 2012; Means, Edinger, Glenn, & Fins, 2003). Extreme sleep discrepancy constitutes an
insomnia subtype known as paradoxical insomnia (AASM, 2014; WHO, 1992). Paradoxical
insomnia (also known as sleep state misperception or subjective insomnia), involves a subjective
complaint of insomnia symptoms without objective evidence of short duration sleep (AASM,
2014). Specifically, paradoxical insomnia requires total sleep time greater than 6.5 hours as
measured by polysomnography (PSG), 85% sleep efficiency (ratio of total sleep time to time in
bed), and less impairment in daytime functioning than would be expected given the severity of
subjective sleep complaints (Research Diagnostic Criteria; Edinger et al., 2004). Patients with
paradoxical insomnia often misperceive sleep duration and sleep onset latency, significantly
underestimating the total amount of time they are asleep and overestimating the amount of time
it takes them to fall asleep (Vanable, Aikens, Tadimeti, Caruana-Montaldo, & Mendelson, 2000;
Tang & Harvey, 2004, 2006; Van den Berg et al., 2008). Despite self-reports of severe sleep
deficits, these individuals do not exhibit daytime sleepiness that would be expected to
accompany sleep insufficiency (Rezaie, Fobian, McCall, & Khazaie, 2018). In contrast to
paradoxical insomnia, psychophysiologic insomnia (also known as objective insomnia) is a
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subtype diagnosed in patients who have objective evidence of insufficient sleep (<6.5 hours)
congruent with self-reported sleep deficits (AASM, 2014).
Sleep Misperception: Patient Characteristics
A key distinction between these two subtypes is the degree of patient accuracy in selfreported sleep compared to objective measures of sleep. Those with psychophysiologic
insomnia have more accurate perceptions about their sleep, whereas those with paradoxical type
exhibit greater sleep discrepancy, overestimating the degree of sleep impairment. Moreover,
individuals who accurately perceive true sleep deficits (psychophysiologic type) are more likely
to have personality profiles consistent with those seen in medical patient populations and have
comorbid medical problems (Fernandez-Mendoza, Calhoun, Bixler, Karataraki, Liao, VelaBueno, Ramos-Platon, et al., 2011; Vgontzas et al., 2013).
In contrast, those who overestimate their sleep impairment (paradoxical type) are more
likely than accurate perceivers to exhibit elevations in the domains of depression and anxiety
(Fernandez-Mendoza et al., 2011). Similarly, patients with both insomnia and depression have
been found to be more likely to exhibit greater sleep discrepancy (Bliwise, Friedman, &
Yesavage, 1993; Edinger & Fins, 1995). It has been suggested that this observed relationship
may be the result of increased psychological distress associated with the perception that one is
not receiving adequate sleep (Harvey & Tang, 2012). Research has found a direct relationship
between anxiety and sleep misperception, such that individuals with higher levels of worry have
been observed to exhibit greater sleep discrepancy (Harvey, 2005).
Identifying the extent to which patients who report sleep difficulties also have sleep
misperceptions and associated clinical characteristics may be important to inform clinical
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decision-making. Vgontzas and colleagues (2013) suggest that patients who accurately perceive
true sleep deficiencies may respond better to biological interventions; therefore, these patients
may directly benefit from immediate initiation of pharmacological treatment to address short
duration sleep. In contrast, patients overestimate sleep impairment may benefit from
interventions that address cognitive, behavioral, or psychological factors before initiating
pharmacological treatment (Moon, Song, & Cho, 2015; Vgontzas et al., 2013).
While sleep misperception is prevalent among problem sleepers, this phenomenon is not
observed among those with good sleep (Manconi et al., 2010). For those who do evidence sleep
misperception, the degree of discrepancy between self-report and objectively measured sleep
varies widely and most do not meet criteria for paradoxical insomnia (Edinger & Fins, 1995;
Harvey & Tang, 2012). Given the ubiquity of sleep misperception among problem sleepers, its’
relative absence among good sleepers, and the variability of discrepancy among misperceivers, it
has been suggested that misperception may be better characterized as dimensional, rather than
categorical (Fernandez-Mendoza et al., 2012; Vgontzas, Fernandez-Mendoza, Liao, & Bixler,
2013). Within this framework, paradoxical insomnia would represent the extreme end of the
misperception continuum (Fernandez-Mendoza et al., 2012; Vgontzas, Fernandez-Mendoza,
Liao, & Bixler, 2013).
Even in the presence of sleep misperception, patients may experience insufficient sleep.
Thus, sleep discrepancy should not be taken as an indication that no sleep disturbance exists but
rather may indicate that an individual perceives her/his sleep to be impaired above and beyond
the true sleep deficit. For instance, a patient with sleep complaints may report sleeping three
hours per night on average, whereas objective testing may reveal that the patient is sleeping five
hours per night. Despite the inaccuracy of the patient’s subjective report, he/she is clearly still

14

experiencing a sleep deficit. In contrast, many sleep under-estimators do achieve sufficient sleep
(Harvey & Tang, 2012). This group may be at elevated risk for developing true sleep deficits,
due to increased anxiety and worry about sleep, associated distress, and heightened vigilance and
arousal that may impair actual sleep (Harvey, 2002; Harvey & Tang, 2012).
Correcting Sleep Misperceptions
Research has explored the possibility of reversing or correcting sleep misperceptions as a
means of improving sleep. In one lab-based polysomnographic study, researchers corrected
misperceptions among participants with paradoxical insomnia by training them to differentiate
sleep from wake during various sleep stages (Downey & Bonnet, 1992). Following the training,
participants were better able to discriminate between sleep and wake and reduced sleep onset
latency (Downey & Bonnet, 1992). Mercer, Lack, and Bootzin (2005) expanded this line of
research using immediate and retrospective feedback during wake periods and following
scheduled awakenings during various sleep stages. Both forms of feedback reduced sleep
misperception and improved sleep in paradoxical insomniacs (Mercer, Lack, & Bootzin, 2005).
These previous studies were limited by small sample sizes and reliance on expensive
equipment (i.e., polysomnography) and specialized technicians. Tang and Harvey (2004)
addressed these limitations in their study, which evaluated a behavioral intervention to correct
sleep misperceptions using wrist actigraphy. The behavioral intervention consisted of an
instruction period in which participants learned to interpret their own actigraphic sleep data
(Tang & Harvey, 2004). Three days post-intervention, those who received the behavioral
intervention reported more accurate sleep perceptions (total sleep time, sleep onset latency),
improved subjective sleep quality (PSQI), and less sleep-related anxiety and preoccupation
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compared to control participants (Tang & Harvey, 2004). Tang and Harvey (2006) extended this
research to include an additional comparison group who received a verbal feedback-only
intervention, without the behavioral or visual components. Similar to the original study,
improvements in self-reported sleep, insomnia symptoms, and sleep-related anxiety and distress
were observed for both intervention conditions, though larger effects were found in the
behavioral intervention group compared to the verbal feedback-only group (Tang & Harvey,
2006). Results of this study were consistent with previous findings that brief corrective feedback
can be effective in reducing sleep discrepancy and improving self-reported sleep. Further, these
results support corrective feedback as a method for reducing cognitive distortions related to
sleep, thereby addressing a characteristic factor known to perpetuate sleep problems (Harvey,
2002).
Quintiliani and colleagues (2017) expanded on Harvey and Tang’s work to examine a
single-session psychoeducational sleep intervention with medical patients diagnosed with
chronic insomnia. In this study, sleep data were collected using wrist actigraphs and sleep
diaries for a total of two weeks. After one week of recording, participants in the treatment group
received a brief feedback intervention during which trained clinicians reviewed actigraphic and
sleep diary results with each individual, emphasizing any sleep discrepancies. Sleep data were
collected from the control group after one week as well but no intervention was provided. All
participants then completed a second week of recording before returning to the clinic to complete
final assessment measures. Consistent with previous studies, improvements in sleep
misperception, sleep-related psychological distress, and subjective sleep quality were observed in
the treatment group (Quintiliani et al., 2017).
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Summary and Study Aims
Preliminary research supports brief corrective feedback interventions to improve sleep
perceptions. Findings to date suggest that brief corrective feedback can be effective in
decreasing sleep discrepancy, improving self-reported sleep quality and quantity, and reducing
sleep-related distress (Downey & Bonnet, 1992; Mercer, Lack, & Bootzin, 2005; Quintiliani et
al., 2017; Tang & Harvey, 2004, 2006). Although such interventions show promise, research has
been conducted only with samples meeting diagnostic criteria for insomnia. Further research is
needed to allow for greater generalizability to populations other than those with diagnosed
insomnia. Specifically, research is needed with problem sleepers more broadly, given the
commonality of sleep misperception among this group as well as the potential preventive effects
of corrective feedback. To date, studies have also used expensive equipment (i.e., PSG,
research-grade actigraphs) for objective sleep measurement. Such equipment is not practical for
routine clinical use, therefore, research using more economical measures is needed to expand the
ecological validity of these findings to clinical practice.
The present study aimed to extend previous work by investigating, in an outpatient
medical setting, the prevalence of sleep misperception among a diverse sample of self-identified
problem sleepers using a commercially available actigraph (Fitbit Charge HR™). Specific study
aims were to:
1) Determine if sleep misperception is present in a sample of self-identified problem
sleepers for total sleep time (TST) and sleep onset latency (SOL).
a. Hypothesis: Discrepancies will be observed between sleep diary and Fitbitmeasures for TST and SOL.
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2) Determine if psychological and medical factors are associated with sleep
misperception (i.e., TST and SOL).
a. Hypothesis: Patients with worse medical health (SF-36 Mental Health
Composite) will have more accurate sleep perceptions (smaller discrepancies).
b. Hypothesis: Patients with higher anxiety and depression (GAD-7, PHQ-9) will
have less accurate sleep perceptions (greater discrepancies).
3) Examine the impact of a single-session feedback intervention in correcting sleep
discrepancies.
a. Hypothesis: Discrepancies between sleep diary and Fitbit-measured sleep
(TST, SOL) will be reduced from baseline to follow-up.
b. Auxiliary hypotheses: Reductions will be observed from baseline to follow-up
for self-reported sleep variables (ISI, sleep diary TST and SOL), medical
functioning (SF-36 Physical Health Composite), and psychological
functioning (SF-36 Mental Health Composite, PHQ-9, GAD-7).
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METHODS
Participants and recruitment
The study was conducted at UCF Health outpatient medical practice. Patients were
recruited as a part of standard clinical practice and within the workflow of medical providers at
UCF Health as well as through printed recruitment flyers placed in the waiting area and exam
rooms and on the UCF Health website. It is well established that sleep problems are often
comorbid with other medical and mental health conditions and patients rarely present with sleep
problems in isolation; therefore, to maximize the clinical relevance and ecological validity of this
study, broad inclusion criteria were used. Patients were invited to participate in the study if they
were 18 years or older, endorsed subjective sleep problems, and were interested in receiving a
non-pharmacological feedback intervention for sleep. Sleep data were collected using the Fitbit
Charge HR™, thus, to be eligible patients had to be willing and able to wear the Fitbit on their
non-dominant wrist. Patients with severe psychological conditions (e.g., suicidality, psychosis),
acute substance use or dependence, and those with diagnosed obstructive sleep apnea who were
not compliant with medical treatment (i.e., use of CPAP) were not eligible for the study. As
pregnant women face a unique set of risk factors they were not eligible for the study. Children
and incarcerated individuals also were not eligible for the study. Participant recruitment began
upon IRB approval in September 2016. All participants were asked to attend three visits at UCF
Health, as detailed below. Enrollment for this study was continuous.
Study design and procedures
Visit 1 (Baseline): Individual assessments were conducted in the patient consultation
rooms at UCF Health. Each participant met individually with the PI to complete consent
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procedures and complete a questionnaire battery consisting of the following measures: Insomnia
Severity Index, Dysfunctional Beliefs and Attitudes about Sleep Scale-16, Epworth Sleepiness
Scale, Pittsburgh Sleep Quality Index, Short Form-36, Generalized Anxiety Disorder-7, Patient
Health Questionnaire-9, and the Alcohol Use Disorders Identification Test (described below and
in Appendices). Information obtained from participant electronic medical records was reviewed
with participants for accuracy (specifically: age, weight, medication list, diagnoses and problem
list). Participants then completed an individual sleep assessment with the PI lasting
approximately 45 minutes and were fitted with the Fitbit Charge HR™, provided with a sleep
diary, and instructed in their use. The instruction period lasted about 15 minutes.
Patients were asked to wear the Fitbit and complete a sleep diary for seven days.
Participants returned to UCF Health approximately one week after the initial visit to complete
the intervention portion of the study.
Visit 2 (Feedback Intervention): Patients returned after recording sleep for one week and
patient sleep data (sleep diary and Fitbit) were reviewed for misperceptions. Each patient
completed the Short Form-36 questionnaire (measure of global health and quality of life) at the
beginning of the feedback session. The intervention consisted of a single session lasting
approximately 30 minutes, during which the participant was provided with written and verbal
feedback about their sleep (see Appendix for sample). The feedback report was based on data
derived from sleep diaries and actigraphic sleep data from the Fitbit Charge HR™, extracted
from Fitabase™, a web-based research platform. All participants received the intervention.
After receiving the feedback intervention, participants were asked to wear the Fitbit and
complete the daily sleep diary for an additional week.
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Visit 3 (Follow-Up): Approximately one week after the feedback session, participants
returned to UCF Health to meet with a study clinician, at which time they returned their
completed sleep diary and Fitbit device. Participants were asked to complete the initial
questionnaire battery again, along with a measure of patient satisfaction (see Appendix J).
Participation in the study was then complete. Patients were provided contact information for the
behavioral health team and were offered the opportunity to initiate services if desired.
Measures
Insomnia Severity Index (ISI; Morin et al., 2003). The ISI is a 7-item self-report
inventory designed to assess the severity of common symptoms of insomnia over the past two
weeks. Items are presented on a Likert scale and individual items range from 0 (none) to 4 (very
severe) and scores are summed to provide a total score ranging from 0 to 28. Scores are
categorized based on the following cutoffs: 0-7 = no clinically significant insomnia; 8-14 =
subthreshold insomnia; 15-21 = clinical insomnia (moderate severity); 22-28 = clinical insomnia
(severe). The ISI has been shown to detect clinically meaningful treatment response (Morin et
al., 2011). Cronbach’s alpha in the present sample was 0.74 at baseline and 0.70 at follow-up.
See Appendix A.
Dysfunctional Beliefs and Attitudes about Sleep Scale – 16 (DBAS-16; Morin,
Vallieres, & Ivers, 2007). The DBAS-16 is a 16-item questionnaire used to assess sleepdisrupting cognitions and beliefs. This measure provides an overall score with higher scores
indicating higher levels of dysfunctional beliefs about sleep. Scores are calculated as the mean
of all item responses and scores greater than four, or any single item response of 6 or more
indicates unrealistic expectations or beliefs about sleep or one’s ability to cope with poor sleep.
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Cronbach’s alpha in the present sample was 0.79 at baseline and 0.88 at follow-up. See
Appendix B.
Epworth Sleepiness Scale (ESS). The ESS is an 8-item self-report measure used to
assess daytime sleepiness. This measure produces a total score ranging from 0 to 24 with
validated cutoffs. A total score of 10 or more or a score of 3 on any item indicates clinically
significant symptoms in need of further evaluation. Cronbach’s alpha in the present sample was
0.83 at baseline and 0.77 at follow-up. See Appendix C.
Short Form-36: Acute (SF-36; Maruish, 1993, 2011). The SF-36 is a 36-item inventory
that measures quality of life across eight domains (physical functioning, bodily pain, role
limitations due to physical health problems, role limitations due to personal or emotional
problems, emotional well-being, social functioning, energy/fatigue, and general health
perceptions). This measure is validated and widely used in medical research. Physical
Component Summary and Mental Component Summary scores were derived from this measure.
Scores falling between 45 and 55 are considered to be in the average range of functioning.
Higher scores indicate better functioning. See Appendix D.
Patient Health Questionnaire-9 (PHQ-9; Kroenke, Spitzer, & Williams, 2001). The
PHQ-9 is a 9-item self-report inventory used to assess the severity of common symptoms of
depression over the past two weeks. Items are presented on a Likert scale with item responses
from 0 = Not at all to 3 = Nearly every day. Total scores range from 0 to 27 with the following
cutoffs: 5-9 = mild; 10-14 = moderate; 15-19 = moderately severe; ≥20 = severe. The PHQ-9
has been validated for use in medical settings. Cronbach’s alpha in the present sample was 0.80
at baseline and 0.81 at follow-up. See Appendix E.
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Generalized Anxiety Disorder-7 (GAD-7; Kroenke, Spitzer, Williams, Monahan, &
Lowe, 2007; Kroenke, Williams, & Lowe, 2006). The GAD-7 is 7-item self-report inventory
designed to assess for the presence and severity of common symptoms of anxiety over the past
two weeks. Items are presented on a Likert scale with item responses from 0 = Not at all to 3 =
Nearly every day. Total scores range from 0 to 21 with the following cutoffs: 5-9 = mild; 10-14
= moderate; ≥15 = severe. This measure is validated for use in medical settings (Kroenke et al.,
2007). Cronbach’s alpha in the present sample was 0.86 at baseline and 0.87 at follow-up. See
Appendix F.
Alcohol Use Disorders Identification Test (AUDIT; Babor, de la Fuente, Saunders, &
Grant, 1992; Saunders, Aasland, Babor, de la Fuente, & Grant, 1993). The AUDIT is a brief
screening tool that is commonly used to assess patients’ alcohol use. This measure provides a
total score with the following cutoffs for alcohol use risk level: 0-7 = low risk; 8-15 = moderate
risk of harm; 16-19 = high risk; ≥20 = likely dependence. Cronbach’s alpha in the present
sample was 0.85 at baseline and 0.88 at follow-up. See Appendix G.
Sleep Outcomes. Sleep outcomes were derived from sleep diaries and a consumer-grade
activity monitor (Fitbit Charge HR™). Data collected from the sleep diary and Fitbit were used
to calculate subjective and objective sleep outcomes, respectively. Sleep outcomes were
calculated as:
Total sleep time (TST): total time (in minutes) between sleep initiation and final
awakening minus WASO (wake after sleep onset).
Sleep onset latency (SOL): amount of time (in minutes) between “lights out” and sleep.
Misperception Index (MI): To assess TST misperception, a Misperception Index (MI;
Manconi et al., 2010) was calculated using the following formula. This formula has
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been suggested as a useful method for quantifying patient accuracy for total sleep time
(Buysse et al., 2006).
MI = [(TSTFitbit – TSTDiary)/TSTFitbit]
Negative index scores indicate TST overestimation and positive scores indicate
underestimation. Plainly stated, patients with positive scores are sleeping more than
they think and patients with negative scores are sleeping less than they think. Scores are
presented on a scale from -1.0 to +1.0. Though it is feasible that negative scores could
be infinite if a patient were to overestimate TST to such a degree. However, such a
report is very unlikely and would represent an extreme outlier. Therefore, consistent
with previous research (Manconi et al., 2010), overestimation scores are truncated at 1.0 for practicality and ease of interpretation.
Sleep diaries are the most widely used measure of sleep functioning and provide a
subjective report of sleep. The Consensus Sleep Diary (CSD-E; Carney et al., 2012) was used in
this study (See Appendix H). Patients were provided written instructions for completing the
diary according. Questions about sleep-interfering behaviors (e.g., prescription/OTC sleep
medication use, caffeine and alcohol consumption) were answered at night, whereas questions
about actual sleep (e.g., awakenings, final wake time) and perceived quality of sleep were
completed in the morning.
The Fitbit Charge HR™ (Fitbit Inc., San Francisco, CA, USA) was used to monitor sleep
as an objective measure of sleep. This Fitbit model has been established in recent research (de
Zambotti et al., 2016). Further, the Fitbit offers an attractive alternative to the gold standards of
PSG and research-grade actigraphy, due to its’ lower cost, availability, and widespread consumer
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use. The device uses tri-axial accelerometer technology to measure gross motor activity
continuously while worn. Patients were asked to wear the device on their non-dominant wrist.
The data were synced to a web-based research platform (Fitabase™), downloaded to a computer,
and analyzed using computer generated algorithms.
Statistical analyses
All data were analyzed using IBM SPSS Version 24.0 (IBM Corp., 2016). Skewness and
kurtosis values were calculated for all outcome and predictor variables to assess for normality
and all fell within the accepted range (George & Mallery, 2010). Paired samples t-tests were
used to evaluate sleep discrepancies between Fitbit and sleep diary measures. Linear regression
analyses were conducted to examine associations between sleep discrepancy variables and
mental and physical health predictor variables. Separate analyses were completed for TST and
SOL. Paired samples t-tests were performed to assess change in sleep and self-report measures
from baseline to follow-up (i.e., one-week post-intervention). Cohen’s d was calculated to
evaluate the magnitude of intervention effects for all pre-post t-test analyses. The following
cutoffs were used to categorize Cohen’s d effect sizes (ES): d = 0.20–0.49 (small); d = 0.50–0.79
(medium); d  0.80 (large). In keeping with the guidelines set out by the National Register for
actigraphic sleep assessment, participants were required to have a minimum of three days of
usable sleep data in order to be included in any analysis of that particular sleep outcome. Those
with less than three days were excluded from analyses for that sleep variable.
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RESULTS
Sample characteristics
Forty-five participants between the ages of 20 and 79 were enrolled in the study. One
participant withdrew less than one week after enrolling due to extenuating personal
circumstances (i.e., family emergency requiring extended travel out of the country) and was
excluded from all analyses. The majority of participants were female (n=27, 60%), identified as
heterosexual (n=44, 98%), and were married (n=25, 56%). Though only 22% of participants had
been previously diagnosed with insomnia, most met diagnostic criteria for either chronic or acute
insomnia (n=43, 95%) at baseline. Seventy-three percent of participants reported at least a
moderate level of insomnia symptoms (ISI  15) at baseline. Thirty-three percent endorsed
moderate or severe depression symptoms (PHQ-9  10) and 31% endorsed moderate or severe
anxiety symptoms (GAD-7  10). Demographic and baseline characteristics are provided in
Tables 4 and 5.
Table 4. Participant demographics
Variable
Age, years
Sex, n (%)
Female
Male
Race, n (%)
Caucasian
Hispanic
African American
Other
Sexual Orientation, n (%)
Heterosexual
Homosexual
Relationship Status, n (%)
Single, never married
In a committed relationship
Married
Divorced
Widowed
Employment Status, n (%)

M
52.71

SD
17.10

27 (60%)
18 (40%)

-

30 (66.7%)
9 (20.0%)
5 (11.1%)
1 (2.2%)

-

44 (97.8%)
1 (2.2%)

-

5 (11.1%)
5 (11.1%)
25 (55.6%)
4 (8.9%)
6 (13.3%)

-
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Variable
Employed
Unemployed
Retired
Disabled
Student
Education, n (%)
Graduate degree
College degree, 4-year
College degree, 2-year
Some college
High school diploma
Other

M
22 (48.9%)
6 (13.3%)
12 (26.7%)
3 (6.7%)
2 (4.4%)

SD
-

11 (24.4%)
15 (33.3%)
7 (15.6%)
8 (17.8%)
3 (6.7%)
1 (2.2%)

Table 5. Participant characteristics at baseline
Variable
Sleep related diagnosis, n (%)^
Insomnia
Obstructive Sleep Apnea
Restless Leg Syndrome
“Sleep difficulties”
Meet diagnostic criteria for Insomnia, n (%)
Chronic
Acute
Sleep medication use, n (%)^
Prescription
OTC
Melatonin
BMI^

M

SD

10 (22.2%)
4 (8.9%)
1 (2.2%)
4 (8.9%)
43 (95.6%)
39 (86.7%)
4 (8.9%)

-

15 (33.3%)
4 (8.9%)
9 (20.0%)
29.23

6.77

^per medical record. BMI = Body mass index; OTC = over the counter.
Sleep discrepancy analyses
Mean discrepancies between Fitbit and sleep diary measures are displayed in Table 6.
Across outcomes and time points, sleep diary reports overestimated sleep impairment compared
to Fitbit measurement. For total sleep time (TST), Fitbit measurements were higher on average
by 52.94 minutes at baseline and 24.20 minutes at one-week follow-up, compared to sleep diary
estimates. For sleep onset latency (SOL), Fitbit measurements were lower on average by 24.99
minutes at baseline and 14.41 minutes at one-week follow-up. Consistent with hypotheses, sleep
misperceptions were observed such that participants underestimated their total amount of sleep
per night and overestimated the amount of time it takes them to fall asleep. See Figures 1 and 2.
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Table 6. Sleep discrepancies at baseline and one-week follow-up
Sleep Feature

N

Fitbit M (SD)

Sleep diary M (SD)

Mean diff (SE)

t

TST, baseline

38

438.34 (66.52)

385.40 (73.74)

52.94 (11.09)

4.78*

TST, follow-up

37

434.97 (61.35)

410.77 (53.63)

24.20 (5.62)

4.31*

SOL, baseline

35

11.67 (10.09)

36.66 (30.23)

-24.99 (4.60)

-5.43^

SOL, follow-up

35

10.47 (10.21)

24.88 (19.48)

-14.41 (2.71)

-5.31*

*p<.001; ^p<.01. TST = total sleep time; SOL = sleep onset latency; TST and SOL are reported
in minutes.

Figure 1. Baseline TST discrepancy

Figure 2. Baseline SOL discrepancy
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Regression analyses
Depression scores significantly predicted SOL discrepancy, b = -.37, t(39) = -2.46, p =
.018 but not TST discrepancy. Physical health scores were not a significant predictor of sleep
discrepancy for SOL or TST. Anxiety scores were not a significant predictor of TST
discrepancy or SOL discrepancy. Unstandardized coefficients, standard errors, and t-values are
displayed in Tables 7 and 8.
Table 7. Unstandardized regression coefficients for predictors of TST Misperception Index
Predictor variable

N

B

SE B

t

p

Physical health (PCS)
Depression (PHQ-9)
Anxiety (GAD-7)

43
43
43

.001
.001
-.009

.002
.005
.005

.54
.27
-2.01

.593
.789
.051

PCS = Physical Composite Scale of the Short-Form-36; PHQ-9 = Patient Health Questionnaire;
GAD-7 = Generalized Anxiety Disorder 7-item scale.
Table 8. Unstandardized regression coefficients for predictors of SOL discrepancy
Predictor variable

N

B

SE B

t

p

Physical health (PCS)

40

.30

.50

.59

.558

Depression (PHQ-9)

40

Anxiety (GAD-7)

40

-2.37
-1.26

.96
1.03

-2.46
-1.22

.018
.228

PCS = Physical Composite Scale of the Short-Form-36; PHQ-9 = Patient Health Questionnaire;
GAD-7 = Generalized Anxiety Disorder 7-item scale.
Intervention effects
Paired samples t-tests were conducted to evaluate changes pre- to post-treatment.
Significant improvements were observed for sleep diary measures of TST and SOL and for TST
discrepancy. Self-reported TST increased on average by 19.69 minutes per night from baseline
to one-week follow-up. Self-reported SOL decreased from baseline, with participants reporting
an average SOL of less than 30 minutes at follow-up. TST discrepancy decreased on average by
31.16 minutes from baseline to follow-up. No significant differences were observed in SOL
discrepancy or in Fitbit measures of TST or SOL from baseline to follow-up. Means, standard
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deviations, t-values, and effect sizes with 95% confidence intervals are displayed in Table 9.
Table 9. Differences in sleep features from baseline to follow-up
Sleep Feature

N

Baseline M (SD)

Follow-up M (SD)

t

d (95% CI)

TST, mean

41

441.88 (65.52)

443.34 (66.39)

-.24

0.04 (-0.40, 0.47)

SOL, mean

42

13.66 (19.01)

10.38 (9.92)

1.36

-0.19 (-0.62, 0.24)

TST, mean

41

392.39 (78.69)

412.08 (53.14)

-2.11^

0.30 (-0.14, 0.73)

SOL, mean

40

39.57 (32.75)

28.32 (26.61)

4.26*

-0.65* (-1.10, -0.20)

TST disc, mean

38

52.34 (68.28)

21.18 (32.51)

3.94*

-0.65* (-1.11, -0.19)

TST MI, mean

38

.11 (.15)

.04 (.08)

SOL disc, mean

37

-24.30 (32.38)

-17.25 (28.38)

4.23*
-1.91

-0.64* (-1.10, -0.18)
0.30 (-0.16, 0.76)

Fitbit Charge HR™

Sleep diary

Sleep discrepancy

*p<.001; ^p<.05. TST = total sleep time; SOL = sleep onset latency; MI = misperception index;
disc = discrepancy between Fitbit and sleep diary. TST and SOL are reported in minutes.
Follow-up was conducted one-week post-intervention.

Figure 3. Fitbit Mean TST Pre-Post Intervention
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Figure 4. Sleep Diary Mean TST Pre-Post Intervention

Figure 5. Fitbit Mean SOL Pre-Post Intervention
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Figure 6. Sleep Diary Mean SOL Pre-Post Intervention

Paired-samples t-tests also revealed significant reductions in insomnia (ISI), depression
(PHQ-9), and anxiety (GAD-7) symptoms from baseline to one-week follow-up. Insomnia
symptom severity decreased from moderately severe to subthreshold insomnia. Depression and
anxiety scores remained in the mild range but evidenced statistically significant improvements
from baseline to follow-up. Mental health scores (SF-36, MCS) improved significantly, falling
within the average range of functioning at follow-up. No significant differences were observed
in sleep beliefs (DBAS), daytime sleepiness (ESS), or physical health functioning (SF-36, PCS)
from baseline to follow-up. Means, standard deviations, t-values, and effect sizes with 95%
confidence intervals are displayed in Table 10.
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Table 10. Differences in self-report measures from baseline to follow-up
Questionnaire

N

Baseline

Follow-up

t

d (95% CI)

Insomnia Severity Index

44

17.14 (4.15)

14.00 (4.22)

Sleep beliefs (DBAS)

43

6.06 (1.56)

5.79 (1.71)

6.68*
1.58

-1.02 (-1.46, -0.57)
-0.26 (-0.69, 0.16)

Epworth Sleepiness Scale

44

8.86 (5.11)

8.23 (4.68)

1.43

-0.21 (-0.63, 0.21)

Physical health composite (PCS)

43

47.29 (10.29)

46.82 (10.46)

.65

-0.10 (-0.52, 0.32)

Mental health composite (MCS)

43

41.62 (11.30)

47.93 (9.28)

-6.48*

0.94 (0.50, 1.39)

Depression symptoms (PHQ-9)

44

8.59 (4.78)

7.23 (4.87)

3.17^

Anxiety symptoms (GAD-7)

44

7.18 (4.75)

5.61 (4.95)

2.53^

-0.48 (-0.91, -0.06)
-0.39 (-0.81, 0.03)

Short Form-36

*p<.001; ^p<.05; d = repeated measures using baseline SD. DBAS = Dysfunctional Beliefs and
Attitudes about Sleep scale; PHQ-9 = Patient Health Questionnaire; GAD-7 = Generalized
Anxiety Disorder 7-item scale.

Figure 7. Insomnia Severity Index Pre-Post Intervention
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Figure 8. Mental Composite Score (SF-36) Pre-Post Intervention

Figure 9. Physical Composite Score (SF-36) Pre-Post Intervention
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Figure 10. Depression scores (PHQ-9) Pre-Post Intervention

Figure 11. Anxiety scores (GAD-7) Pre-Post Intervention

Patient Perceptions of Intervention
Descriptive statistics were examined for the patient perceptions measure completed at
follow-up. Overall, participants reported positive responses and perceptions of the feedback
intervention. All participants indicated that the feedback was useful and informative and that
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they had a better understanding of their own sleep patterns after receiving the intervention.
Eighty percent of participants believed the Fitbit accurately measured their sleep and all
participants found the device easy to use. Sixty-five percent reported that they intend to
purchase a Fitbit or other sleep monitoring device after completing the study. Lastly, all
participants would recommend this study to others and a most (91%) endorsed interest in having
consumer technology incorporated into routine clinical care. See Figures 12-19.

Useful
100

Percent

80
60
40
20
0
Disagree Strongly

Disagree Slightly

Agree Slightly

The personalized sleep feedback was useful.

Figure 12. Perception of feedback as useful
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Agree Strongly

Informative
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The personalized sleep feedback was informative.

Figure 13. Perception of feedback as informative

Better Understanding
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I have a better understanding of my sleep patterns after participating in
this study.

Figure 14. Perception of feedback as helpful in understanding sleep
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Accuracy
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I believe the Fitbit Charge HR™ accurately measured my sleep patterns.

Figure 15. Perception of Fitbit as accurate

Ease of Use
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The Fitbit Charge HR™ was easy to use.

Figure 16. Perception of Fitbit as easy to use
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Plan to Purchase
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I plan to purchase a Fitbit™ or another sleep monitoring device after
participating in this study.

Figure 17. Plan to purchase a Fitbit

Would Recommend
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I would recommend this study to a friend or family member with sleep
problems.

Figure 18. Would recommend study to others
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Routine Care
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I would like for my physician to use consumer technology products (e.g.,
Fitbit™, mobile apps) as a part of routine care.

Figure 19. Participants perception of consumer products in routine care
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DISCUSSION
Results of the present study are consistent with previous findings, showing that sleep
misperception is prevalent among problem sleepers and that sleep discrepancy can be reduced
through the use of corrective sleep feedback. This study expands on previous research to
examine sleep misperception in a diverse outpatient medical sample of self-identified problem
sleepers, using consumer-grade wearable actigraphs.
Similar to previous studies (Morin & Benca, 2012; Quintilliani et al., 2017), objectively
measured TST and SOL remained relatively unchanged from baseline to follow-up. Despite this
lack of change in actual sleep, participants perceived themselves to be sleeping more hours per
night, falling asleep more quickly, and sleeping better overall at one-week follow-up. Perceived
sleep impairment has been shown to cause sleep-related anxiety and distress and can result in
objective sleep impairment, even among those without true impairment previously (Harvey &
Tang, 2012; Mercer, Bootzin, & Lack, 2002). In the present study, nearly 70% of participants
were sleeping the recommended minimum of seven hours per night on average at baseline,
whereas only 31% believed they were sleeping at least seven hours. This population of
misperceivers may be at risk for developing objective sleep impairment. This finding has
important clinical implications. Given the malleability of sleep misperception, it is feasible that
corrective sleep feedback could disrupt the cycle of insomnia by reducing sleep discrepancy and
subsequently reducing sleep-related anxiety and distress (Quintiliani et al., 2017; Semler &
Harvey, 2005).
The present study also sought to explore predictors of sleep misperception. As
hypothesized, depression was found to predict SOL discrepancy, such that those with elevated
depression scores were more likely to report larger overestimations of SOL. However, contrary
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to previous research (Fernandez-Mendoza et al., 2011; Vgontzas et al., 2013), TST
misperception was not associated with elevations in depression or anxiety nor did poor physical
health predict lower levels of sleep discrepancy in the present study. Previous work in support of
these relationships was conducted primarily with paradoxical or psychophysiologic insomnia
samples and represent extreme ends on a continuum of sleep misperception (Fernandez-Mendoza
et al., 2011; Vgontzas et al., 2013). As such, it is possible that mental and physical health may
predict sleep misperception only among the most severe cases which were not represented in the
Primary Care patient sample of the present study.
Pre-post changes in self-reported sleep, mood, and health were examined as a secondary
aim in this study. Statistically significant improvements in depression, anxiety, mental health
functioning, and insomnia symptom severity were observed at one-week follow-up. Daytime
sleepiness and physical health functioning both remained relatively unchanged, falling within a
normal range at baseline and follow-up. Dysfunctional sleep beliefs did not change significantly
from baseline to follow-up. Overall, these findings suggest that a single-session corrective sleep
feedback intervention is associated with improvements in self-reported sleep, mood, anxiety, and
mental health functioning.
Limitations. The present study has some notable limitations. This study did not include
a control group to compare response to intervention, as such, improvements in secondary
outcomes of depression, anxiety, and mental health functioning should be interpreted with
caution as they may just represent the passage of time. Further, findings are restricted to shortterm follow-up in this study. Longitudinal studies are needed to evaluate intermediate and longterm effects of corrective feedback on sleep perception, sleep-related distress, and objectively
measured sleep. Longer-term follow up would also provide an opportunity to explore the
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potential preventive impact of corrective feedback, examining if there may be a buffering effect
on a population health level within medical practices. Such effects have been reported for
corrective feedback when applied to other health behaviors (Dotson, Bowers, & Dunn, 2015). A
relatively small sample was included in this study, limiting statistical power. Future research
should be conducted with larger samples.
Challenges in using technology were also evident in the present study. Early in the study
it was apparent that there was a seemingly systematic error with the Fitbits which resulted in the
first night of data not being recorded for most participants. This issue was not able to be
resolved during the course of the study and, though the majority of participants were able to
successfully record at least five nights of data, this highlights the continued challenges of
conducting research using consumer devices.
Moreover, consumer actigraphs are limited in measurement precision, however, they
provide greater ecological validity in evaluating the utility of patient-generated health data
(PGHD) in clinical practice. It is important to note that future research and clinical practice
should seriously consider this and employ such consumer-grade products within the context of
this limitation. Systemic issues and limitations should also be considered as the field continues
to develop and explore the clinical utility of consumer devices and PGHD. Probably most
important is the question of standardization.
Future Directions. Though participants were instructed to wear the Fitbit a minimum of
one hour before bed until one hour after waking, they were encouraged to wear the device
throughout the day if they were so inclined. It would be interesting to explore differences
between those who elected to wear the Fitbit all day to track steps, activity, or heart rate and
those who wore it only during required periods, as this may elucidate differences in engagement
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and may offer insight into the target users who may benefit from technology-driven interventions
for multiple health behavior change. Researchers should consider evaluating overall engagement
with consumer devices in future studies, as participants who are more invested may be more
likely to engage in self-management and take a more active role in their own health and
wellbeing.
Research should not only explore the viability of consumer devices for assessing and
intervening on sleep pathology but should also examine their potential as a tool for promoting
and maintaining sleep health. This framework is particularly attractive from a population and
public health perspective. Moreover, given the typical developmental course from acute to
chronic sleep disturbance and insomnia, a health promotion approach seems to be a promising
prevention effort worth further consideration.
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The Insomnia Severity Index
Please rate the current (i.e., last 2 weeks) severity of your insomnia problem(s).
None

Mild

Moderate

Severe

Very

a.

Difficulty falling asleep:

0

1

2

3

4

b.

Difficulty staying asleep:

0

1

2

3

4

c.

Problem waking up too
early:

0

1

2

3

4

How satisfied/dissatisfied are you with your current sleep pattern?
Very satisfied

Satisfied

Neutral

Dissatisfied

Very dissatisfied

0

1

2

3

4

To what extent do you consider your sleep problem to interfere with your daily functioning (e.g.,
daytime fatigue, ability to function at work/daily chores, concentration, memory, mood, etc.)?
Not at all
interfering

A little

Somewhat

Much

Very much
interfering

0

1

2

3

4

How noticeable to others do you think your sleeping problem is in terms of impairing the quality
of your life?
Not at all
noticeable

A little

Somewhat

Much

Very much
noticeable

0

1

2

3

4

How worried/distressed are you about your current sleep problem?
Not at all
worried

A little

Somewhat

Much

Very much
worried

0

1

2

3

4
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Beliefs About Sleep
Several statements reflecting people’s beliefs and attitudes about sleep are listed below.
Please indicate (by circling the number) to what extent you personally agree or disagree with
each statement. There is no right or wrong answer. For each statement, circle a number that
best reflects your personal experience. Consider the whole scale, rather than only the
extremes of the continuum.
1. I need 8 hours of sleep to feel refreshed
and function well during the day.

Strongly
Disagree

0

1

2

3

4

5

6

7

8

9

10

Strongly
Agree

2. When I do not get proper amount of
sleep on a given night, I need to catch up
on the next day by napping or on the
next night by sleeping longer.

Strongly
Disagree

0

1

2

3

4

5

6

7

8

9

10

Strongly
Agree

3. I am concerned that chronic insomnia
may have serious consequences for my
physical health.

Strongly
Disagree

0

1

2

3

4

5

6

7

8

9

10

Strongly
Agree

4. I am worried that I may lose control over
my abilities to sleep.

Strongly
Disagree

0

1

2

3

4

5

6

7

8

9

10

Strongly
Agree

5. After a poor night’s sleep, I know that it
will interfere with my daily activities on
the next day.

Strongly
Disagree

0

1

2

3

4

5

6

7

8

9

10

Strongly
Agree

6. In order to be alert and function well
during the day, I am better off taking a
sleeping pill rather than having a poor
night’s sleep.

Strongly
Disagree

0

1

2

3

4

5

6

7

8

9

10

Strongly
Agree

7. When I feel irritable, depressed, or
anxious during the day, it is mostly
because I did not sleep well the night
before.

Strongly
Disagree

0

1

2

3

4

5

6

7

8

9

10

Strongly
Agree

8. When I sleep poorly on one night, I know
that it will disturb my sleep schedule for
the whole week.

Strongly
Disagree

0

1

2

3

4

5

6

7

8

9

10

Strongly
Agree

9. Without an adequate night’s sleep, I can
hardly function the next day.

Strongly
Disagree

0

1

2

3

4

5

6

7

8

9

10

Strongly
Agree

10. I can’t ever predict whether I will have a
good or poor night’s sleep.

Strongly
Disagree

0

1

2

3

4

5

6

7

8

9

10

Strongly
Agree

11. I have little ability to manage the
negative consequences of disturbed
sleep.

Strongly
Disagree

0

1

2

3

4

5

6

7

8

9

10

Strongly
Agree

12. When I feel tired, have no energy, or just

Strongly
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Strongly

seem not to function well during the day,
it is generally because I did not sleep
well the night before.

Disagree

0

1

2

3

4

5

6

7

8

9

10

Agree

13. I believe that insomnia is essentially a
result of a chemical imbalance.

Strongly
Disagree

0

1

2

3

4

5

6

7

8

9

10

Strongly
Agree

14. I feel that insomnia is ruining my ability to
enjoy life and prevents me from doing
what I want.

Strongly
Disagree

0

1

2

3

4

5

6

7

8

9

10

Strongly
Agree

15. Medication is probably the only solution
to sleeplessness.

Strongly
Disagree

0

1

2

3

4

5

6

7

8

9

10

Strongly
Agree

16. I avoid or cancel obligations (social,
family, occupational) after a poor night’s
sleep.

Strongly
Disagree

0

1

2

3

4

5

6

7

8

9

10

Strongly
Agree
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Your Health and Well-Being
This survey asks for your views about your health. This information will
help keep track of how you feel and how well you are able to do your usual
activities. Thank you for completing this survey!
For each of the following questions, please mark an
describes your answer.

in the one box that best

1. In general, would you say your health is:

  

Excellent

1

Very good

Good

2

3

 
Fair

Poor

4

5

2. Compared to one week ago, how would you rate your health in general
now?
Much better
now than one
week ago

Somewhat
better
now than one
week ago

About the
same as one
week ago

Somewhat
worse
now than one
week ago

Much worse
now than one
week ago

    
1

2

3
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4

5

3. The following questions are about activities you might do during a typical
day. Does your health now limit you in these activities? If so, how much?
Yes,
limited
a lot

Yes,
limited
a little

No, not
limited
at all

  

Vigorous activities, such as running, lifting
heavy objects, participating in strenuous sports ......................

1

.............

2

.............

3

Moderate activities, such as moving a table, pushing
a vacuum cleaner, bowling, or playing golf.............................

1

.............

2

.............

3

c

Lifting or carrying groceries ....................................................

1

.............

2

.............

3

d

Climbing several flights of stairs .............................................

1

.............

2

.............

3

e

Climbing one flight of stairs ....................................................

1

.............

2

.............

3

f

Bending, kneeling, or stooping ................................................

1

.............

2

.............

3

g

Walking more than a mile........................................................

1

.............

2

.............

3

h

Walking several hundred yards ...............................................

1

.............

2

.............

3

i

Walking one hundred yards .....................................................

1

.............

2

.............

3

j

Bathing or dressing yourself ....................................................

1

.............

2

.............

3

a

b
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4. During the past week, how much of the time have you had any of the
following problems with your work or other regular daily activities as a
result of your physical health?
All of
the time

a

b

c

d

Most of
the time

Some of
the time

A little of
the time

None of
the time

    

Cut down on the amount of
time you spent on work or
other activities..................................

1

..............

2

..............

3

..............

4

.............

5

Accomplished less than you
would like ........................................

1

..............

2

..............

3

..............

4

.............

5

Were limited in the kind of
work or other activities ....................

1

..............

2

..............

3

..............

4

.............

5

Had difficulty performing the
work or other activities (for
example, it took extra effort) ...........

1

..............

2

..............

3

..............

4

.............

5

5. During the past week, how much of the time have you had any of the
following problems with your work or other regular daily activities as a
result of any emotional problems (such as feeling depressed or anxious)?
All of
the time

a

b

c

Most of
the time

Some of
the time

A little of
the time

None of
the time

    

Cut down on the amount of
time you spent on work or
other activities..................................

1

..............

2

..............

3

..............

4

.............

5

Accomplished less than you
would like ........................................

1

..............

2

..............

3

..............

4

.............

5

Did work or other activities
less carefully than usual ...................

1

..............

2

..............

3

..............

4

.............

5
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6. During the past week, to what extent has your physical health or
emotional problems interfered with your normal social activities with
family, friends, neighbors, or groups?

    

Not at all

Slightly

1

Moderately

2

Quite a bit

3

Extremely

4

5

7. How much bodily pain have you had during the past week?

     
None

Very mild

1

Mild

2

Moderate

3

Severe

4

Very severe

5

6

8. During the past week, how much did pain interfere with your normal
work (including both work outside the home and housework)?

    

Not at all

1

A little bit

Moderately

2

3
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Quite a bit

4

Extremely

5

9. These questions are about how you feel and how things have been with
you during the past week. For each question, please give the one answer
that comes closest to the way you have been feeling. How much of the time
during the past week…
All of
the time

Most of
the time

Some of
the time

A little of
the time

None of
the time

    

a

Did you feel full of life? ..................

1

..............

2

..............

3

..............

4

..............

5

b

Have you been very nervous? ..........

1

..............

2

..............

3

..............

4

..............

5

Have you felt so down in the
dumps that nothing could
cheer you up? ...................................

1

..............

2

..............

3

..............

4

..............

5

Have you felt calm and
peaceful? ..........................................

1

..............

2

..............

3

..............

4

..............

5

Did you have a lot of energy? ..........

1

..............

2

..............

3

..............

4

..............

5

Have you felt downhearted
and depressed? .................................

1

..............

2

..............

3

..............

4

..............

5

g

Did you feel worn out? ....................

1

..............

2

..............

3

..............

4

..............

5

h

Have you been happy? .....................

1

..............

2

..............

3

..............

4

..............

5

i

Did you feel tired? ...........................

1

..............

2

..............

3

..............

4

..............

5

c

d

e

f

10. During the past week, how much of the time has your physical health or
emotional problems interfered with your social activities (like visiting with
friends, relatives, etc.)?
All of
the time

Most of
the time

Some of
the time

A little of
the time

None of
the time

    
1

2

3
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4

5

11. How TRUE or FALSE is each of the following statements for you?
Definitely
true

Mostly
true

Don’t
know

Mostly
false

Definitely
false

    

a

b

c

d

I seem to get sick a little
easier than other people ..................

1

..............

2

.............

3

I am as healthy as
anybody I know ..............................

1

..............

2

.............

3

I expect my health to
get worse .........................................

1

..............

2

.............

3

My health is excellent .....................

1

..............

2

.............

3

...............

4

..............

5

...............

4

..............

5

...............

4

..............

5

...............

4

..............

5

Thank you for completing these questions!
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Sleep Diary Instructions (CSD-E)
General Instructions
What is a Sleep Diary? A sleep diary is designed to gather information about your daily sleep pattern.
How often and when do I fill out the sleep diary? It is necessary for you to complete your sleep diary every
day. If possible, the sleep diary should be completed within one hour of getting out of bed in the morning. The
Nighttime Sleep Diary questions can be completed before you go to bed at night.
What should I do if I miss a day? If you forget to fill in the diary or are unable to finish it, leave the diary blank
for that day.
What if something unusual affects my sleep or how I feel in the daytime? If your sleep or daytime
functioning is affected by some unusual event (such as an illness, or an emergency) you may make brief notes
on your diary.
What do the words “bed” and “day” mean on the diary? This diary can be used for people who are awake or
asleep at unusual times. In the sleep diary, the word “day” is the time when you choose or are required to be
awake. The term “bed” means the place where you usually sleep.
Will answering these questions about my sleep keep me awake? This is not usually a problem. You should
not worry about giving exact times, and you should not watch the clock. Just give your best estimate.

Morning Sleep Diary Item Instructions
Use the guide below to clarify what is being asked for each item of the Sleep Diary.
Date: Write the date of the morning you are filling out the diary.
1. What time did you get into bed? Write the time that you got into bed. This may not be the time you
began “trying” to fall asleep.
2. What time did you try to go to sleep? Record the time that you began “trying” to fall asleep.
3. How long did it take you to fall asleep? Beginning at the time you wrote in question 2, how long did it
take you to fall asleep.
4. How many times did you wake up, not counting your final awakening? How many times did you wake up
between the time you first fell asleep and your final awakening?
5. In total, how long did these awakenings last? What was the total time you were awake between the
time you first fell asleep and your final awakening. For example, if you woke 3 times for 20 minutes, 35
minutes, and 15 minutes, add them all up (20+35+15= 70 min or 1 hr and 10 min).
6a. What time was your final awakening? Record the last time you woke up in the morning.
6b. After your final awakening, how long did you spend in bed trying to sleep? After the last time you woke-up
(Item #6a), how many minutes did you spend in bed trying to sleep? For example, if you woke up at 8 am but
continued to try and sleep until 9 am, record 1 hour.
6c. Did you wake up earlier than you planned? If you woke up or were awakened earlier than you planned,
check yes. If you woke up at your planned time, check no.
6d. If yes, how much earlier? If you answered “yes” to question 6c, write the number of minutes you woke
up earlier than you had planned on waking up. For example, if you woke up 15 minutes before the alarm
went off, record 15 minutes here.
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7. What time did you get out of bed for the day? What time did you get out of bed with no further attempt
at sleeping? This may be different from your final awakening time (e.g. you may have woken up at
6:35 a.m. but did not get out of bed to start your day until 7:20 a.m.)
8. In total, how long did you sleep? This should just be your best estimate, based on when you went to
bed and woke up, how long it took you to fall asleep, and how long you were awake. You do not need
to calculate this by adding and subtracting; just give your best estimate.
9. How would you rate the quality of your sleep? “Sleep Quality” is your sense of whether your sleep
was good or poor.
10. How restful or refreshed did you feel when you woke up for the day? This refers to how you felt after
you were done sleeping for the night, during the first few minutes that you were awake.

Nighttime Sleep Diary Item Instructions
Please complete the following items before you go to bed.
Date: Write the date of the evening you are filling out the diary.
11a. How many times did you nap or doze? A nap is a time you decided to sleep during the day,
whether in bed or not in bed. “Dozing” is a time you may have nodded off for a few minutes, without
meaning to, such as while watching TV. Count all the times you napped or dozed at any time from
when you first got out of bed in the morning until you got into bed again at night.
11b. In total, how long did you nap or doze? Estimate the total amount of time you spent napping or
dozing, in hours and minutes. For instance, if you napped twice, once for 30 minutes and once for 60
minutes, and dozed for 10 minutes, you would answer “1 hour 40 minutes.” If you did not nap or doze,
write “N/A” (not applicable).
12a. How many drinks containing alcohol did you have? Enter the number of alcoholic drinks you had
where 1 drink is defined as one 12 oz beer (can), 5 oz wine, or 1.5 oz liquor (one shot).
12b. What time was your last drink? If you had an alcoholic drink yesterday, enter the time of day in
hours and minutes of your last drink. If you did not have a drink, write “N/A” (not applicable).
13a. How many caffeinated drinks (coffee, tea, soda, energy drinks) did you have? Enter the number
of caffeinated drinks (coffee, tea, soda, energy drinks) you had where for coffee and tea, one drink =
6-8 oz; while for caffeinated soda one drink = 12 oz.
13b. What time was your last drink? If you had a caffeinated drink, enter the time of day in hours and
minutes of your last drink. If you did not have a caffeinated drink, write “N/A” (not applicable).
14. Did you take any over-the-counter or prescription medication(s) to help you sleep? If so, list
medication(s), dose, and time taken: List the medication name, how much and when you took EACH
different medication you took tonight to help you sleep. Include medication available over the counter,
prescription medications, and herbals (example: "Sleepwell 50 mg 11 pm"). If every night is the same,
write “same” after the first day
15. Comments If you have anything that you would like to say that is relevant to your sleep feel free to
write it here.
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For each of the following questions, please mark an X in the box that best describes your answer.
Disagree Disagree Agree
Strongly Slightly
Slightly
1

Agree
Strongly

I believe the Fitbit Charge HR™ accurately measured my sleep
patterns.

2 The Fitbit Charge HR™ was easy to use.
3

I plan to purchase a Fitbit™ or another sleep monitoring device
after participating in this study.

4

I have a better understanding of my sleep patterns after
participating in this study.

5 The personalized sleep feedback was informative.
6 The personalized sleep feedback was useful.
I would recommend this study to a friend or family member
7
with sleep problems.
I would like for my physician to use consumer technology
8
products (e.g., Fitbit™, mobile apps) as a part of routine care.
Please provide any comments or feedback that you may have for the researcher in the space below:
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Sleep Feedback Report
The following feedback report is based on behavioral sleep measurement data collected from the
Fitbit Charge HR over the course of one week. This device uses accelerometer technology to
detect your movement and activity level during sleep. Your sleep data was extracted and
analyzed in 60-second increments using a specialized research platform to provide a reliable
estimate of your sleep pattern. Below is a summary and a graphic illustration of your sleep data.
During the nights when you wore the Fitbit, the average time you fell asleep was 11:31 PM and
your average total sleep duration was 6 hours and 38 minutes, with total sleep time ranging from
6 hours and 15 minutes to 7 hours and 1 minute. In contrast, during your initial visit (xx/xx/xx)
you estimated that you sleep approximately 4 hours and 30 minutes per night, on average. Based
on your sleep diary, you reported sleeping an average of 5 hours and 36 minutes per night during
the past week. Taken together these results indicate that, on average you slept 56 minutes more
per night than you thought during the past week (based on sleep diary) and approximately 2
hours and 8 minutes more per night than you estimated at your initial visit. The National Sleep
Foundation recommends that adults sleep at least 7 hours per night and based on this standard
your sleep results indicate that you are generally getting slightly less than adequate sleep.
When taking into consideration all 6 nights of recording, the total amount of time you spent
awake after initially falling asleep was 1 hour and 43 minutes and this amount ranged from 9
minutes to 26 minutes per night. Results also indicated that you were quite restless, with an
average of 34 restless minutes per night and a total of 3 hours and 24 minutes of restlessness
across all 6 nights.
Overall, results of your sleep assessment suggest that you sleep more hours per night than you
expected and that you are receiving an inadequate amount of sleep on average. Also, your sleep
is very fragmented and restless throughout the night.

Keri Dotson, M.S.
Doctoral Candidate, Clinical Psychology
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Disclaimer: The data presented herein were collected using the Fitbit Charge HR™ as part of a research study for
which you volunteered to participate. The Fitbit Charge HR™ is not a medical device and has not been evaluated by
the FDA for this purpose. This report aims to provide an exploratory interpretation based on data collected from the
Fitbit™ for research purposes. The information provided in this report does not constitute a medical diagnosis or
medical advice and is not intended to be a substitute for professional medical treatment. Do not disregard
professional medical advice or delay seeking advice or treatment because of something you have read here.
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University of Central Florida Institutional Review Board
Office of Research & Commercialization
12201 Research Parkway, Suite 501
Orlando, Florida 32826-3246
Telephone: 407-823-2901 or 407-882-2276
www.research.ucf.edu/compliance/irb.html

Approval of Human Research
From:

UCF Institutional Review Board #1
FWA00000351, IRB00001138

To:

Keri B. Dotson and Co-PIs: Jeffrey E. Cassisi & Maria Louise Cannarozzi

Date:

September 15, 2016

Dear Researcher:
On 09/15/2016 the IRB approved the following human participant research until 09/14/2017 inclusive:
Type of Review:
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